JOHNSON & JOHNSON
JNJ
43 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Sep 4 6:37 PM | Taubert Jennifer L | Proposed Sale | 56,471 | $177.81 | $10.0M | — | View → |
| Aug 29, 2025 | Aug 29 7:36 PM | Forminard Elizabeth | Proposed Sale | 9,570 | $177.20 | $1.7M | — | View → |
| Aug 22, 2025 | Aug 22 5:58 PM | Duato Joaquin | Proposed Sale | 125,824 | $180.04 | $22.7M | — | View → |
| Aug 15, 2025 | Aug 15 7:57 PM | Wolk Joseph J | Proposed Sale | 16,820 | $176.91 | $3.0M | — | View → |
| Jul 17, 2025 | Jul 17 8:05 PM | REED JOHN C | Proposed Sale | 19,137 | $163.55 | $3.1M | — | View → |
| Feb 25, 2025 | Feb 25 8:05 PM | Decker Robert J | Proposed Sale | 6,999 | $165.88 | $1.2M | — | View → |
| Feb 7, 2025 | Feb 7 6:27 PM | Wolk Joseph J | Proposed Sale | 13,015 | $153.89 | $2.0M | — | View → |
| Dec 4, 2024 | Dec 4 6:25 PM | Hait William | Proposed Sale | 25,742 | $149.90 | $3.9M | — | View → |
| Aug 30, 2024 | Aug 30 7:51 PM | Decker Robert J | Proposed Sale | 5,635 | $165.06 | $930.1K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 51,418 | $165.89 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Grant/Award | 18,162 | $243.45 | 1,217(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 1,241 | — | 1,268(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 14,357 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Grant/Award | 21,781 | $243.45 | 1,459(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 994 | — | 1,150(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 4,012 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 64,693 | $131.94 | 33,000(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 3,849 | — | 3,754(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Grant/Award | 57,656 | $243.45 | 3,863(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 39,242 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Option Exercise | 683 | — | 687(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Grant/Award | 5,571 | $243.45 | 700(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Option Exercise | 3,053 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 51,648 | $157.92 | 59,854(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Grant/Award | 52,928 | $243.45 | 3,546(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 3,196 | — | 3,692(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Grant/Award | 29,020 | $243.45 | 1,944(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 2,024 | — | 2,126(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 14,357 | — | 0(D) | View → |